DCM
TEVA icon

Davis Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Davis Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$2K Hold
135
– – ﹤0.01% 249
2020
Q1 		$1K Buy
+135
New +$1.38K ﹤0.01% 256

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Davis Capital Management's TEVA Position: Q2 2020 in Review

Davis Capital Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2020 at 135 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #249.

Davis Capital Management first reported a position in TEVA in Q1 2020 and has held it in 2 quarters since. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Davis Capital Management held 135 shares of Teva Pharmaceutical Industries Limited worth $2K as of Q2 2020.
  • Davis Capital Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2020.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2020, its #249 holding.
  • Davis Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2020 and has held it in 2 quarters since.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2020.

Based on Davis Capital Management's 13F filing for Q2 2020, filed 29 Jul 2020.